Introduction {#s1}
============

Many proteins undergo co- or post-translational modifications, including phosphorylation, acetylation, and glycosylation to fulfill their functions (Walsh and Jefferis, [@B57]; Carubbi et al., [@B5]). It is estimated that glycosylation modifications are associated with approximately 50% of human proteins (Clerc et al., [@B9]; Oliveira-Ferrer et al., [@B38]) and 30% of approved biopharmaceutical proteins (Zou et al., [@B67]), which are critical for important biological processes in living systems, such as cell\'s adhesion, recognition, targeting, and differentiation (Varki, [@B55]; Bhat et al., [@B4]). Despite the importance of glycosylations, rigorous evaluation of the relationship between the precise structure and biological function of glycoproteins is complicated by the structural heterogeneity of the oligosaccharides in biological organisms, and the difficulty to obtain sufficient amounts of structure-defined glycoproteins with single glycoform from natural sources (Park et al., [@B39]).

In order to develop viable and efficient strategies to chemically construct homogeneous complex *N*-linked glycopeptides and glycoproteins, extensive efforts and advances have been made in the field (Payne and Wong, [@B41]; Wilson et al., [@B64]; Okamoto et al., [@B36]; Wang and Amin, [@B59]; Fairbanks, [@B16]; Li et al., [@B28]), such as the resin-bound glycosylation (Kunz and Unverzagt, [@B25]; Vetter et al., [@B56]; Offer et al., [@B35]; Mezzato et al., [@B32]; Kajihara et al., [@B21]; Yamamoto et al., [@B65]; Piontek et al., [@B42],[@B43]; Chen and Tolbert, [@B7]; Conroy et al., [@B12]; Ullmann et al., [@B54]; Okamoto et al., [@B37]; Reif et al., [@B45]; Lee et al., [@B26]; Schöwe et al., [@B49]) and solution glycosylation (Anisfeld and Lansbury, [@B2]; Cohen-Anisfeld and Lansbury, [@B11]; Kaneshiro and Michael, [@B22]; Wang et al., [@B62], [@B60], [@B61]; Aussedat et al., [@B3]; Nagorny et al., [@B34]; Sakamoto et al., [@B46]; Joseph et al., [@B20]; Chai et al., [@B6]; Schöwe et al., [@B49]). However, unneglectable limitations still remain in these strategies. Consumption of large amount of precious materials and low coupling yields usually occurred for the glycopeptide assembly on-resin via either the stepwise ([Scheme 1A](#S1){ref-type="scheme"}) or the convergent ([Scheme 1B](#S1){ref-type="scheme"}) strategy. Based on the aspartylation technology pioneered by Lansbury and co-workers ([Scheme 1C](#S1){ref-type="scheme"}) (Anisfeld and Lansbury, [@B2]; Cohen-Anisfeld and Lansbury, [@B11]), Danishefsky group and Unverzagt group developed the synthetic methods and optimized the pseudoproline dipeptide building block to construct the peptide fragement at the site of Asn-Xaa-Ser/Thr, and this approach significantly suppressed the formation of aspartimide byproducts during glycosylation (Ullmann et al., [@B54]; Wang et al., [@B60]). Although useful, requirement for additional metal catalysts or protected *C*-terminal carboxylic acid derivatives may limit the application of this strategy in glycopeptide assembly.

![Effective strategies for chemical construction of *N*-linked glycopeptides: **(A)** stepwise strategy via solid-phase; **(B)** convergent strategy via solid-phase; **(C)** convergent strategy via solution phase.](fchem-08-00396-g0004){#S1}

Notwithstanding substantial advances have been made in *N*-linked glycopeptides and glycoproteins synthesis, it is still a great challenge to efficiently achieve large *N*-linked gylcoproteins bearing complex glycan forms. The desired synthetic methods will have fewer protecting groups and modifications on the peptide and glycan fragments, and promote efficient and selective ligation reactions between fragments. Previously, our research group has developed a strategy for the convergent synthesis of *N*-linked glycopeptides via peptidyl ω-Asp *p*-nitrophenyl thioester-assisted glycosylation ([Scheme 1C](#S1){ref-type="scheme"}) (Du et al., [@B14]). This convergent strategy with direct aminolysis provides an access to complex *N*-linked glycopeptides, usually with good yields and simple operation, and is worthy of further investigating more reactions and applications.

Many investigators have proved that coupling of peptide fragments via direct aminolysis is a feasible method for preparation of peptides and glycopeptides. This method employs direct coupling reaction between peptide fragments bearing *N*-terminal free amines and peptide fragments bearing *C*-terminal active esters, such as oxoesters (Kemp and Vellaccio, [@B23]; Wan et al., [@B58]; Li et al., [@B27]), thioesters (Payne et al., [@B40]; Agrigento et al., [@B1]; LingáTung and Clarence, [@B30]; Gui et al., [@B18]) or selenoester derivatives (Grieco et al., [@B17]; Mitchell et al., [@B33]; Raj et al., [@B44]; Takei et al., [@B52]; Temperini et al., [@B53]; Du et al., [@B15]; Sayers et al., [@B47],[@B48]; Chisholm et al., [@B8]; Wang et al., [@B63]), eliminates the need for *N*-terminal cysteine residues or thiol ligation auxiliaries, which are generally required for the sequential native chemical ligation (Dawson et al., [@B13]; Kent, [@B24]). Notably, the active selenoesters or derivatives always offer enhanced reactivity compared to the thio- or oxoesters (Mitchell et al., [@B33]; Raj et al., [@B44]; Takei et al., [@B52]). Our previous studies have shown that the aminolysis of peptidyl selenoester is an efficient strategy for peptide and glycopeptide assembly (Yin et al., [@B66]; Du et al., [@B15]). Herein we are interested in pursuing a highly reactive peptidyl ω-Asp selenoester-assisted glycosylation methodology for constructing *N*-linked glycopeptides without coupling reagents ([Scheme 1C](#S1){ref-type="scheme"}). This methodology is assumed to be compatible with free carboxylic groups and hydroxyl groups of peptides and glycans.

Results and Discussion {#s2}
======================

Evaluation of the Reactivity of the Active Esters for Glycosidic Amide Bond Formation
-------------------------------------------------------------------------------------

To evaluate the methods for synthesizing *N*-linked glycopeptide synthesis via active ester-assisted aminolysis (Du et al., [@B14]), the activity and efficiency of different active esters were compared and investigated using model reactions, in which Fmoc-Gly ester **2** and glycosylamine **1a** (Likhosherstov et al., [@B29]; Cohen-Anisfeld and Lansbury, [@B11]) were condensed in DMSO to form β-anomer product **3** and monitored by HPLC ([Table 1](#T1){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}).

###### 

Optimization of the active esters for the glycosylation reaction[^a^](#TN1){ref-type="table-fn"}.

  ![](fchem-08-00396-i0001.jpg)                                      
  ------------------------------- -------- ---- ------- ----- ------ -----
  1                               **2a**   O    H       H     \>40   \<1
  2                               **2b**   S    H       H     \>40   8
  3                               **2c**   S    NO~2~   H     10     75
  4                               **2d**   Se   H       H     2      92
  5                               **2e**   Se   H       CHO   1      69
  6                               **2f**   Se   CHO     H     1      67

*Reaction conditions: **1a** (10 μmol), esters (5 μmol) and DIPEA (10 μmol) in 1 mL of DMSO, rt*.

*Consumption of \>95% of the starting ester in glycosylation reaction was determined by HPLC*.

*Determined by HPLC at 40 h*.

![Reaction curves (yields of **3** vs. time) of the glycosidic linkage formation between **2a−2f** and **1a**.](fchem-08-00396-g0001){#F1}

For oxoester **2a**, it has the lowest activity and almost no product was observed ([Table 1](#T1){ref-type="table"}, entry 1). For thioesters ([Table 1](#T1){ref-type="table"}, entries 2-3), phenyl thioester **2b** underwent glycosidic bond formation slightly faster than the oxoester **2a**, but it is not efficient enough to be applied in the *N*-linked glycopeptide synthesis; *p*-nitrophenyl thioester **2c** with a strong electron-withdrawing group reacts more efficiently, providing the target product in a yield of 75% within 10 h, which is consistent with previous studies (Hondal et al., [@B19]; Du et al., [@B14]). Therefore, the peptidyl *p*-nitrophenyl thioester has been successfully utilized to prepare *N*-linked glycopeptide in our lab (Du et al., [@B14]).

To improve the efficiency of glycosylation reaction, various selenoesters were assessed under the same conditions ([Table 1](#T1){ref-type="table"}, entries 4--6). For seleno-phenyl ester **2d**, it underwent complete conversion within 2 h, and afforded the target product **3** in 92% yield; for seleno-benzaldehyde esters **2e** with the *o*-benzaldehyde group and **2f** with the *p*-benzaldehyde group (Raj et al., [@B44]), they underwent complete conversion in \<1 h, and gave the products in yield of 69 and 67%, respectively. We postulate that the participation of *o*-benzaldehyde (neighbor-participating group) and *p*-benzaldehyde, which both have electron-withdrawing groups can increase the phenyl selenoester\'s electrophile reaction rate, but also facilitate the hydrolysis reaction and reduce the yield of aminolysis product. Therefore, the seleno-phenyl ester **2d** affords an optimal balance between high reactivity and sufficient stability, will be appropriate for the selenoester-assisted aminolysis in glycosylation reactions.

As shown in [Table 2](#T2){ref-type="table"}, we compared the reaction kinetic data *p*-nitrophenyl thioester **2c** and seleno-phenyl ester **2d**. As expected, the glycosylation reaction for the product **3** between glycine-derived ester and glycosylamine follows a second-order kinetics, with a rate constant 0.0071 ± 0.0004 M^−1^ s^−1^ for **2c** and 0.0420 ± 0.0012 M^−1^ s^−1^ for **2d**, respectively. The seleno-phenyl ester is roughly 6-times faster than the *p*-nitrophenyl thioester to form the glycosidic amide bond.

###### 

Kinetic studies for glycosidic bond formation[^a^](#TN4){ref-type="table-fn"}.

  ![](fchem-08-00396-i0002.jpg)                                                                                      
  ------------------------------- ------- -------------- -------------- -------------------------------------------- --------------------
  **Ester**                       **X**   **R**~**1**~   **R**~**2**~   ***K*** **\[M**^**−1**^**s**^**−1**^**\]**   **Relative rates**
  **2c**                          S       NO~2~          H              0.0071 ± 0.0004                              1
  **2d**                          Se      H              H              0.0420 ± 0.0012                              6

*Reaction conditions: **1a** (10 μmol), esters (5 μmol) and DIPEA (10 μmol) in 1 mL of DMSO, rt*.

Condition Optimization
----------------------

As depicted in [Table 3](#T3){ref-type="table"}, various glycosylation reaction conditions were evaluated for further optimization. From the results of optimizing the solvent ([Table 3](#T3){ref-type="table"}, entries 1--4), the efficiency of the glycosylation reaction was shown to be greatly boosted in DMSO, but the aqueous solution of NMP/PB is prone to decompose the seleno-phenyl ester **2d**. The amounts of DIPEA from 0.1 to 3.0 equivalents didn\'t significantly influence the yields ([Table 3](#T3){ref-type="table"}, entries 4--7). Additionally, we found that the product **3** was achieved in optimal yield when seleno-phenyl ester **2d** was treated with 2.0 equivalents of glycosylamine **1a** ([Table 3](#T3){ref-type="table"}, entries 4, 8--9). In order to maximize the glycosylation and minimize the hydrolysis, we selected the optimum conditions, i.e., 2.0 equivalents of DIPEA and glycosylamine **1a**, and 1.0 equivalent of seleno-phenyl ester **2d** were dissolved in DMSO.

###### 

Reaction optimization and control experiments[^a^](#TN5){ref-type="table-fn"}.

  ![](fchem-08-00396-i0003.jpg)                                                                          
  ------------------------------- ----------------- ----------------- ------------- -------------------- -----------------------------------------------
  **Entry**                       **1a (equiv.)**   **2d (equiv.)**   **Solvent**   **DIPEA (equiv.)**   **Yield (%)[^b^](#TN6){ref-type="table-fn"}**
  1                               2                 1                 NMP/PB        2                    52
  2                               2                 1                 NMP           2                    78
  3                               2                 1                 DMF           2                    76
  4                               2                 1                 DMSO          2                    92
  5                               2                 1                 DMSO          3                    90
  6                               2                 1                 DMSO          1                    88
  7                               2                 1                 DMSO          0.1                  85
  8                               1                 1                 DMSO          2                    70
  9                               3                 1                 DMSO          2                    93

*Reaction conditions: **1a** (5-15 μmol), ester **2d** (5 μmol) and DIPEA (10 μmol) in 1mL of solvent, rt*.

*Determined by HPLC at 2 h. PB = phosphate buffer (pH 7.4, 0.2 M)*.

Substrate Scope
---------------

To explore the universal applicability of selenoester-assisted glycosylation, we embarked on the attachment of seleno-phenyl esters to a series of peptides to assemble peptidyl ω-Asp selenoester substrates, and examined substrates that incorporating the free *C*-terminal carboxylic groups and unprotected glycosylamines. A series of partially protected peptides bearing selenoesters at the ω-aspartyl terminus (including pseudoproline dipeptides that suppress aspartimide formation) were successfully prepared for evaluation (Ullmann et al., [@B54]; Wang et al., [@B60]). These peptide substrates were conducted via stepwise solid-phase peptide synthesis (SPPS), the general synthetic procedures for **4b-12b** are outlined in [Figure 2](#F2){ref-type="fig"} (more details are shown in the [Supporting Information](#SM1){ref-type="supplementary-material"}). The installation of phenyl selenoester group at the ω-aspartyl terminus is straightforward on the resin: firstly, the allyl esters were removed; subsequently, the ω-aspartyl carboxyl groups were converted to selenoesters (**4a-12a**); finally, these peptidyl selenoesters were cleaved from the resin. The ω-aspartyl selenoester peptide substrates (**4b-12b**) were isolated via reverse-phase HPLC purification in 58--83% yields. In addition, the glycosylamines ([Figure 3](#F3){ref-type="fig"}) for the study are monosaccharide **1a**, chitobiose **1b** and undecasaccharide **1c** (extracted from fresh egg yolks) (Seko et al., [@B50]; Sun et al., [@B51]).

![Solid-phase synthesis of peptidyl selenoesters **4b-12b**.](fchem-08-00396-g0002){#F2}

![Structures of glycosylamines **1a-1c**.](fchem-08-00396-g0003){#F3}

With peptidyl selenoesters and glycosylamines in hand, the glycosylation reactions at the site of natural ω-asparagine linkage were evaluated. On the one hand, the coupling of monosaccharide **1a** and peptides **4b-6b** gave glycosylated peptides **4c-6c** in approximately 69%-83% isolated yields ([Table 4](#T4){ref-type="table"}, entries 1--3), proving the feasibility of utilizing unprotected glycosylamines together with peptidyl selenoesters bearing free *C*-terminal carboxylic groups in glycosylation reactions. To our delight, peptide **7b** containing two ω-asparagine selenoesters, still gave an isolated yield of 80% of product **7c** derived from multiply glycosylated protein erythropoietin (EPO; fragment 22--43) (Park et al., [@B39]; Wang et al., [@B61]; Wilson et al., [@B64]) with two glycosylation modifications ([Table 4](#T4){ref-type="table"}, entry 4). On the other hand, this strategy also afforded good results for glycosylation of disaccharides. As shown in entries 5--7, coupling of chitobiose **1b** and peptidyl selenoesters **5b**, **8b**, and **9b** formed glycosidic bond at ω-asparagine residue with excellent yields.

###### 

Scope of the peptidyl selenoester-based glycosylation[^a^](#TN7){ref-type="table-fn"}.

  -----------------------------------------------------------------------------------------------------------------------
  **Entry**                       **Peptide + glycan ratio (P:G)**   **Product**                     **Isolated yield**
  ------------------------------- ---------------------------------- ------------------------------- --------------------
  ![](fchem-08-00396-i0004.jpg)                                                                      

  1                               **4b** **+** **1a**\               ![](fchem-08-00396-i0005.jpg)   69%
                                  (1:2)                                                              

  2                               **5b** **+** **1a**\               ![](fchem-08-00396-i0006.jpg)   83%
                                  (1:2)                                                              

  3                               **6b** **+** **1a**\               ![](fchem-08-00396-i0007.jpg)   78%
                                  (1:2)                                                              

  4                               **7b** **+** **1a**\               ![](fchem-08-00396-i0008.jpg)   80%
                                  (1:2)                                                              

  5                               **5b** **+** **1b**\               ![](fchem-08-00396-i0009.jpg)   79%
                                  (1:2)                                                              

  6                               **8b** **+** **1b**\               ![](fchem-08-00396-i0010.jpg)   82%
                                  (1:2)                                                              

  7                               **9b** **+** **1b**\               ![](fchem-08-00396-i0011.jpg)   84%
                                  (1:2)                                                              
  -----------------------------------------------------------------------------------------------------------------------

*Reaction conditions: **1a** (10 μmol), selenoester peptides (5 μmol) and DIPEA (10 μmol) in 1 mL of DMSO, rt, 2 h*.

For this methodology, it is noteworthy that the desired *N*-linked glycopeptides are synthesized rapidly only through mixing two substrates, without using a condensation reagent, and the workup procedure is simple. Excitingly, the free carboxylic groups of ω-aspartyl peptide segments were readily converted into peptidyl selenoesters for further condensation with various glycosylamines. Additionally, each amino acid protecting group in glycopeptide can be easily removed in an acidic environment.

Syntheses of *N*-Linked Glycopeptides With Complex-Type Oligosaccharide
-----------------------------------------------------------------------

As shown in [Table 5](#T5){ref-type="table"}, the protocol of selenoester-mediated glycopeptide synthesis is extended to complex-type oligosaccharide amines. Given the structural complexity of the precious undecasaccharide amine **1c**, an excessive amount of peptidyl selenoester (1.5:1) was used, and the final products (**10e**, **11e**, **12e**) of the peptides modified with undecasaccharides were achieved in good yields of 59--65% ([Table 5](#T5){ref-type="table"}, entries 1--3). Specially, product **12e** corresponds to the truncated segment of the glycoprotein found in human interleukin-5 (IL-5, an eosinophil chemotactic factor, fragment 26--43) (Coffman et al., [@B10]; Liu and Dong, [@B31]).

###### 

Selenoester-mediated glycosylation[^a^](#TN8){ref-type="table-fn"}.

  -----------------------------------------------------------------------------------------------------------------------
  **Entry**                       **Peptide + glycan ratio (P:G)**   **Product**                     **Isolated yield**
  ------------------------------- ---------------------------------- ------------------------------- --------------------
  ![](fchem-08-00396-i0012.jpg)                                                                      

  1                               **10b** **+** **1c**\              ![](fchem-08-00396-i0013.jpg)   65%
                                  (1:1.5)                                                            

  2                               **11b** **+** **1c**\              ![](fchem-08-00396-i0014.jpg)   59%
                                  (1:1.5)                                                            

  3                               **12b** **+** **1c**\              ![](fchem-08-00396-i0015.jpg)   62%
                                  (1:1.5)                                                            
  -----------------------------------------------------------------------------------------------------------------------

*Reaction conditions: **1c** (3 μmol), **10b-12b** (2 μmol), DIPEA (4 μmol) in 0.5 mL of DMSO, 4 Å MS, rt, 6 h*.

Conclusion {#s3}
==========

In this work we have developed a convergent and facile synthetic methodology to construct homogeneous *N*-linked glycopeptides from the peptides with ω-Asp phenyl selenoester, the use of peptidyl selenoesters has the merits of simple operation and obtained excellent yields of *N*-linked glycopeptides, such as truncated segments derived from glycoprotein EPO or IL-5. This selenoester-mediated glycosylation provides several advantages: the reactivity of the peptide ester is improved, the complex sialyloligosaccharide in its native form without protection, it is not only compatible with free *C*-terminal carboxylic acid groups, but also rapidly forms glycosidic bond without additional coupling reagents or catalysts. This method will be further applied to the formation of homogenous *N*-linked glycopeptides and glycoproteins with therapeutic potential.
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